Results 291 to 300 of about 194,403 (335)

How CGM Use in Adults With Type 2 Diabetes Leads to Glycemic Benefits: The Role of Medication and Behaviour Change

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
This 6‐month study of CGM use in adults with T2D found greater HbA1c reduction was independently predicted by self‐care changes and by starting a new medication immediately before study start. Behaviour changes were most strongly predictive of glycemic benefit among participants who hadn't started a new medication before study start.
William H. Polonsky   +6 more
wiley   +1 more source

Avidity-Based Capture of PD-L1-Expressing Exosomes via Dendrimer-Peptide Conjugates: A Nanoengineered Platform for Enhanced Prediction of Immunotherapy Response. [PDF]

open access: yesAdv Sci (Weinh)
Lee J   +15 more
europepmc   +1 more source

Selenium and Liver Steatosis and Fibrosis: Opposing Direct and Steatosis‐Mediated Associations in a Large Cohort

open access: yesJGH Open, Volume 10, Issue 5, May 2026.
ABSTRACT Background and Aims Epidemiologic studies have reported conflicting associations between selenium exposure and liver disease. Whether selenium exerts opposing direct and steatosis‐mediated effects on liver fibrosis is unknown. To evaluate the associations of blood selenium with elastography‐defined hepatic steatosis and fibrosis and to ...
Neda Rehan   +2 more
wiley   +1 more source

Levels and Effects of Nogo-B in Patients With Type 2 Diabetes or Hyperglycemic HUVEC Model. [PDF]

open access: yesEndocrinol Diabetes Metab
Irakoze L   +13 more
europepmc   +1 more source

Evaluation of the effects of thymoquinone on fracture healing in experimental bone fractures in rats. [PDF]

open access: yesJt Dis Relat Surg
Yıldırım Dİ   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy